|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.02 HKD | +2.42% |
|
+5.56% | -44.51% |
Genscript Biotech Corporation reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 839.53 million compared to USD 625.7 million a year ago. Net loss was USD 95.48 million compared to USD 226.85 million a year ago.
Basic loss per share from continuing operations was USD 0.0453 compared to USD 0.1082 a year ago. Diluted loss per share from continuing operations was USD 0.0453 compared to USD 0.1082 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -44.51% | 2.99B | |
| +1.51% | 42.75B | |
| +8.57% | 41.34B | |
| +49.22% | 41.61B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
GENSCRIPT BIOTECH CORPORATION 
